中药饮片和中成药重复用药评价标准的构建
x

请在关注微信后,向客服人员索取文件

篇名: 中药饮片和中成药重复用药评价标准的构建
TITLE: Establishment of Evaluation Criteria for Repeated Usage of TCM Decoction Pieces and Chinese Patent Medicine
摘要: 目的:构建临床中药饮片和中成药重复用药处方评价标准,为临床中(成)药处方点评提供参考。方法:采用改进德尔菲法,选择临床经验丰富的15位中医药专家,进行两轮问卷调查,收集问卷数据、整合专家意见,在此基础上建立中药饮片和中成药重复用药评价指标体系。结果:两轮问卷中,专家积极系数均为100%,权威程度分别为0.711、0.752;问卷信度分别为0.830、0.926;专家的协调系数分别为0.579(P<0.01)、0.721(P<0.01)。最终构建了包含4个一级条目(组分重复、功能与主治重复、毒理重复、其他)、10个二级条目的中药饮片和中成药重复用药评价标准。结论:参与构建标准的专家积极系数及其权威程度较高,问卷信度良好;初步形成了中药饮片和中成药重复用药评价标准。
ABSTRACT: OBJECTIVE:To estab lish the evaluation criteria for repeated usage of TCM decoction pieces and Chinese patent medicine,and to provide reference for prescription comment. METHODS :By modified Delphi method ,15 experts of TCM were selected,who had plenty of clinical experience. The questionnaire data and expert opinion were collected and summarized to establish related evaluation index system with two rounds of questionnaire survey. RESULTS :In this two-rounded survey ,experts’ positive coefficients were 100%;authority coefficient were 0.711 and 0.752;reliability of questionaire were 0.830 and 0.926; coordination degree of experts were 0.579(P<0.01)and 0.721(P<0.01),respectively. The evaluation criteria for cross-using and repeated usage of TCM decoction pieces and Chinese patent medicine ,which contained 4 first-level items (component repetition,function and indication repetition ,tumor repetition and others )and 10 second-level items ,were established finally. CONCLUSIONS:Established criteria are with well expert ’s positive coefficient and high authority ,and good reliability of questionnaire. The evaluation criteria for repeated usage of TCM decoction pieces and Chinese patent medicine is formulated preliminarily.
期刊: 2020年第31卷第19期
作者: 胡珀,金炎,沈夕坤,李孟洋,胡芳
AUTHORS: HU Po,JIN Yan,SHEN Xikun,LI Mengyang,HU Fang
关键字: 改进德尔菲法;重复用药;中药饮片;中成药;合理用药
KEYWORDS: Modified Delphi method ;Repeated medication ;TCM decoction pieces ;Chinese patent medicine ;Rational drug
阅读数: 662 次
本月下载数: 14 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!